Podcasts about Cardiology

This week we review the topic of mitral annular disjunction ("MAD") and the possible association with ventricular arrhythmia or sudden death in the connective tissue disease patient. Is there a 'cut off' distance above which patients deserve more significant arrhythmia surveillance? What is the best way to measure the MAD distance? Can patients with low MAD distances have lower degrees or even no arrhythmic surveillance? How often should this distance be measured on CMR and can an echo measurement provide similar data? Dr. Daniel Castellanos, the first author of this work and Assistant Professor of Pediatrics at Harvard Medical School shares his deep insights this week.DOI: 10.1016/j.jocmr.2025.101954

Send us a textAccording to the American Heart Association, Afib affects an estimated 5 million Americans today, and 12 million are projected to have it by 2030. Returning to the podcast to discuss Atrial Fibrillation is Dr. Talha Farid, cardiologist with St. Luke's Heart Care Clinic. To learn more about heart care services at St. Luke's Hospital, visit unitypoint.org/cr-heart.Do you have a question about a trending medical topic? Ask Dr. Arnold! Submit your question and it may be answered by Dr. Arnold on the podcast! Submit your questions at: https://www.unitypoint.org/cedarrapids/submit-a-question-for-the-mailbag.aspxIf you have a topic you'd like Dr. Arnold to discuss with a guest on the podcast, shoot us an email at stlukescr@unitypoint.org.

Dr. Carole Keim welcomes pediatric cardiologist Dr. Tal Gospin, MD, to The Baby Manual to talk about what pediatric cardiology is and how it differs from adult cardiology. Dr. Gospin explains how much of pediatric cardiology is concerned with congenital heart disease, abnormalities people are born with. She watches for the shape of an infant's heart and the sounds it makes, even in utero, and discusses exactly what she looks for with Dr. Keim. They explore fetal echocardiograms, infant heart function, and what parents can watch for in newborns to see if a pediatric cardiologist needs to be consulted. Dr. Gospin and Dr. Keim discuss when a baby's heart murmur should be referred to a pediatric cardiologist and the differences between an innocent murmur and a pathologic murmur. Innocent murmurs that appear in newborns typically disappear in infancy. Dr. Gospin shares that some types of pediatric cardiac issues will show up as a lack of weight gain in infants, and when to reach out to a pediatrician for a referral. They talk about echocardiograms and what to expect, whether the baby feels any discomfort or not from an EKG, and what the scans are looking for. They discuss breathholding episodes, fainting, and explain what's happening and what a parent can do. This episode provides a lot of insight into pediatric cardiology and gives parents insight into the functioning of their infant's heart.  Dr. Tal Gospin, MD:Dr. Tal Gospin graduated with honors from Washington University in St. Louis with her undergraduate degree in Psychology. She obtained a Masters in Physiology and her Medical Doctorate from Georgetown University School of Medicine, where she was elected into Alpha Omega Alpha, the National Medical Honor Society. Dr. Gospin continued on to pursue a pediatrics residency at New York Presbyterian Hospital/Columbia University in New York City. She then completed her fellowship in pediatric cardiology at Baylor College of Medicine/Texas Children's Hospital in Houston, Texas. Dr. Gospin's fellowship training included caring for patients with a broad spectrum of cardiac conditions and working with leading experts in the field of pediatric cardiology and cardiac surgery. She concentrated her fellowship training on echocardiography, outpatient care for children with complex congenital heart disease, as well as fetal imaging and prenatal counseling.Dr. Gospin is board-certified in Pediatrics and Pediatric Cardiology. She is a fellow of the American Academy of Pediatrics and the American College of Cardiology. Her clinical interests include transthoracic echocardiography, fetal imaging, evaluation and treatment of children with congenital and acquired heart disease, pediatric arrhythmias, as well as hypercholesterolemia and hypertension. Dr. Gospin brings her diverse knowledge base and training into the community to provide comprehensive medical care with a passion for personalized attention.__ Resources discussed in this episode:The Holistic Mamas Handbook is available on AmazonThe Baby Manual is also available on Amazon__Contact Dr. Carole Keim, MDlinktree | tiktok | Instagram Contact Dr. Tal Gospin, MDwebsite | Pediatric Cardiology Care Houston Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Dr. Amro Alsaid, Medical Director of Advanced Cardiac Imaging, and Dr. Karim Al-Azizi, Medical Director of the Catheterization Laboratory and Structural Heart Program at Baylor Scott & White The Heart Hospital, discuss how AI and advanced cardiac imaging are reshaping coronary diagnosis, improving precision in patient care, and optimizing workflow efficiency across cardiology programs.Visit Cleerly Health to learn more. https://cleerlyhealth.com/what-is-cleerly?utm_campaign=cleerly_brand&utm_medium=podcast&utm_source=beckers&utm_content=pr-podcast-11-2025

In this episode of the Heart podcast, Digital Media Editor, Professor James Rudd, is joined by Dr Frances Varian from the University of Sheffield, UK. They discuss her insights as a cardiologist and geography graduate working in the NHS with respect to the environmental impact of climate change on our health. Dr Varian is leading the British Cardiovascular Society's environment and sustainability committee. They also explore how cardiovascular care and research both have environmental impacts and what we can do individually and at a population level to reduce this impact. Please see the links below for more information.   If you enjoy the show, please leave us a positive review wherever you get your podcasts. It helps us reach more people - thank you! Links: ESC strategic plan 2023-2028 (includes sustainability)  RCP green physicians toolkit Quantifying the carbon footprint of clinical trials  Clinical trials carbon footprint guidance Carbon footprint calculator (Travel) Food - BBC Climate Change food calculator

Screening, evaluation, and CVD risk assessment Medical science has finally recognized the link between chronic, low-grade inflammation and cardiovascular disease! In this episode of Live Foreverish, Dr. Mike and Dr. Crystal share the details on the latest guidelines published by the Americal College of Cardiology which provides action forward steps you can take today to detect and decrease your risk of having a heart attack or stroke. #LELearn #EDULiveforeverish

Listener feedback on the PISCES trial, AHA news (including a big PCSK9i trial), beta-blockers post MI, LAAC, and post-AF ablation OAC use are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I Listener Feedback Why I Believe Fish Oil's Big CV Benefit in Dialysis Patients https://www.medscape.com/viewarticle/why-i-believe-fish-oils-big-cv-benefit-dialysis-patients-2025a1000uzg PISCES trial https://www.nejm.org/doi/full/10.1056/NEJMoa2513032 II PCSK9 Inhibitor News In Global Trial, PCSK9 Inhibitor Provides Major Protection Against First CV Event https://www.medscape.com/viewarticle/global-trial-pcsk9-inhibitor-provides-major-protection-2025a1000uzp VESALIUS-CV trial https://www.nejm.org/doi/full/10.1056/NEJMoa2514428 ODYSSEY trial https://www.nejm.org/doi/full/10.1056/NEJMoa1801174 FOURIER https://www.nejm.org/doi/full/10.1056/NEJMoa1615664 Anish Koka Tweet on LDL-lowering https://x.com/anish_koka/status/1987280506937909326?s=20 III Beta-Blockers After MI and John Cleland Beta-Blockers after MI with normal EF https://www.nejm.org/doi/full/10.1056/NEJMoa2512686 REBOOT-CNIC trial https://www.nejm.org/doi/full/10.1056/NEJMoa2504735 REDUCE AMI trial https://academic.oup.com/ehjcvp/article/9/2/192/6895544?login=false ABYSS trial https://www.nejm.org/doi/full/10.1056/NEJMoa2404204 CAPITAL RCT trial https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0199347 Beta-Blockers after MI with mildly reduced EF https://pubmed.ncbi.nlm.nih.gov/40897190/ John Cleland Clinical Outlook https://www.nature.com/articles/s41569-025-01228-w IV Left Atrial Appendage Closure – The CLOSURE-AF trial Percutaneous LAAC in AF Falls Short Again in CLOSURE-AF https://www.medscape.com/viewarticle/percutaneous-left-atrial-appendage-closure-af-falls-short-2025a1000uzu Prague-17 Trial https://www.jacc.org/doi/10.1016/j.jacc.2020.04.067 OPTION trial https://www.nejm.org/doi/full/10.1056/NEJMoa2408308 V Oral AC after AF ablation – the OCEAN Trial Anticoagulation After AF Ablation: The OCEAN Trial Still Leaves Questions https://www.medscape.com/viewarticle/anticoagulation-after-af-ablation-ocean-trial-still-leaves-2025a1000v4t OCEAN Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2509688 ALONE-AF trial https://jamanetwork.com/journals/jama/fullarticle/2838294 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

This week we review a recent retrospective review from Phoenix Children's Hospital about coronary artery fistulae. How common are they and who needed intervention? How should the cardiologist think about the small fistula? Should they all be ‘followed' or can they be discharged from cardiology follow-up? How small is ‘small enough'? We speak with Dr. Marie Chevenon who is a fetal cardiologist at Phoenix Children's Hospital about her recent study on the Phoenix experience with coronary artery fistulae.  https://doi.org/10.1007/s00246-024-03600-y

On today's Good Day Health Show - ON DEMAND…Dr. Jack Stockwell, a NUCCA Chiropractor and GAPS Practitioner in SLC, UT (866.867.5070 | ForbiddenDoctor.com | JackStockwell.com), covers the the biggest news in the health and wellness space from a holistic, naturopath perspective. Dr. Jack just returned from a several-day conference seminar in Minneapolis where he was speaking 10 150+ doctors on two separate mornings, and one of the things he was speaking on and wanted to share on the Good Day Health Program is heart health. With all of the technology we have today, and miraculous surgeries, heart disease is still the number 1 killer in America. So what's missing? Why are deadly cardiac events still killing people at an alarming rate, making it the number 1 way to die for Americans. Additionally, the whole nutritional complex works best with heart disease problems, when the reality is that good food choices lead to better health. Then, Doug joins Dr. Jack to address listener questions, including the mind-body connection between what's manifested physically from stress and psychosomatic symptoms.Website: GoodDayHealthrShow.com Social Media: @GoodDayNetworks

On this “Meet the Experts” HeartTalk, host Melanie Lawson, MS, sits down with MedAxiom President and CEO Jerry Blackwell, MD, MBA, FACC, for a candid conversation about leadership, teamwork, and service – drawing lessons from both medicine and his early days in sports. He shares how trust and humility guide his approach and why he sees change as something to run toward, not from. Plus, he shares a few personal insights (and laughs) that reveal what keeps him grounded through it all.Guest Bio:Jerry Blackwell, MD, MBA, FACCPresident and CEO, MedAxiomAs the President and Chief Executive Officer (CEO) of MedAxiom, Jerry guides the course of the organization with a passion for physician leadership, teaching and care transformation – particularly team-based care and organizational performance improvement. He maintains a clinical practice with special interests in advanced imaging, including cardiovascular MRI, CCTA and cardiac PET.He has more than 30 years of experience in cardiovascular medicine, including academic cardiology, private practice and large integrated cardiovascular group leadership. Most recently, he served as executive vice president and chief clinical officer of the Ballad Health System. Blackwell has been involved with both MedAxiom and the American College of Cardiology (ACC) for many years. He has served on the ACC's Board of Governors, the Board of Directors for the Cardiology Advocacy Alliance, and the ACC's Health Affairs Committee.Blackwell graduated from Marshall University's Joan C. Edwards School of Medicine and completed residency/chief residency/fellowship at the Ohio State University and the University of Alabama - Birmingham. He earned his executive MBA from the University of Tennessee.Watch the episode here:https://youtu.be/DzbM7n75aVs

https://www.tadeclinicagem.com.br/guia/?utm_source=whatsapp&utm_medium=social&utm_term=&utm_content=&utm_campaign=Guia-blackfriday&utm_source_platform=&utm_creative_format=&utm_marketing_tactic=

On today's Good Day Health Show - ON DEMAND…Host Doug Stephan and Dr. Ken Kronhaus of Lake Cardiology (352-735-1400) cover a number of topics affecting our health. First up, Doug and Dr. Ken discuss the biggest news stories in the medical world, starting with the cardio-protection that's coming from some of the GLP-1 drugs, an investigative study into how GLP-1 drugs my affect people's risk for developing cancer, how many of these studies are funded by government grants that seem to be in jeopardy vs what is funded by drug companies.Moving on, research shows highlights that the duration of walking matters, with a daily 60-minute walk contributes to longevity and a healthier heart. Another study brings the conversation to low-dose aspirin (AKA baby aspirin) and how it helps those with Type II diabetes. Once upon a time, baby aspirin was given to nearly everyone to prevent he first heart attack, but now the pendulum has swung to far the other way with people who could benefit from it not having the conversations with their doctors about whether or not it's beneficial.Next, there is a new three-pronged blood test that can predict heart attack risk, a surprising find that melatonin to help with sleep may be putting themselves at risk for future heart problems, and how AI can help doctors detect sepsis.Lastly, Doug and Dr. Ken address listener questions, including the benefits of listening to music for those above the age of 70, is there such a thing as too much protein and what are the side effects, and the best multivitamins to add to your health plan.  Website: GoodDayHealthrShow.com Social Media: @GoodDayNetworks

Cardiovascular disease is the No. 1 killer of women nationwide, yet during midlife—the crucial time for prevention—many women fall out of regular medical care.Host Dr. Rachel Pope is joined by Dr. Lisa Larkin, an internal medicine and women's health expert and founder of Ms. Medicine. They discuss why women's cardiovascular risk spikes around menopause and what you can do about it now.The Midlife Risk SpikeDr. Larkin highlights a failure in the healthcare system: women aged 40 to 60 often receive the least medical care, right when prevention is most critical.The perimenopausal transition causes rapid and significant metabolic changes: Cholesterol rises and HDL protection declines. Development of insulin resistance. Increase in visceral fat (the "risky fat" around organs), which is a marker for cardiovascular disease.Standard risk tools often underestimate risk in women because they don't account for sex-specific factors like adverse pregnancy outcomes (preeclampsia, gestational diabetes). Women are also often allowed to run higher blood pressures, missing opportunities for early intervention.Management & The "Missed Boat" QuestionDr. Larkin stresses that Body Composition is more important than BMI, as most women gain risky visceral fat during this time. She recommends tracking body composition annually.For women in their mid-60s who ask if they've missed the boat on prevention or Hormone Therapy (HT): Assessment is Key: Dr. Larkin performs a highly individualized assessment, often utilizing a Coronary Calcium Score to check for established plaque. If Risk is Low: A patient with perfect health metrics and a Calcium Score of zero may still be a candidate for HT to treat symptoms and support bone health. If Risk is High: The priority is to aggressively fix every single risk factor (hypertension, elevated lipids) before considering hormones, as established plaque may carry more risk with estrogen.Dr. Larkin emphasizes that women must be their best advocates because the healthcare system is currently failing to provide the comprehensive care needed during this pivotal stage of life.

Listener feedback on non-culprit PCI in STEMI, a major cardiac result in patients on hemodialysis, news on GLP-1 agonists, a dubious stroke trial, and an AHA preview are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I Listener Feedback Meta-analysis of MI as a surrogate https://pubmed.ncbi.nlm.nih.gov/34694318/ Compare Acute Trial https://www.nejm.org/doi/full/10.1056/NEJMoa1701067 DANAMI-3–PRIMULTI 10.1016/S0140-6736(15)60648-1 External Link CULPRIT-SHOCK https://www.nejm.org/doi/full/10.1056/NEJMoa1710261   II  Huge Cardiac News for Patients with ESRD PISCES article EMBARGOED Till 1130 AM EST PISCES Trial www.nejm.org/doi/full/10.1056/NEJMoa2513032 REDUCE-IT Trial https://www.nejm.org/doi/full/10.1056/NEJMoa1812792 STRENGTH Trial https://jamanetwork.com/journals/jama/fullarticle/2773120 FISH trial https://jamanetwork.com/journals/jama/fullarticle/1150094 III Obesity Agents White House announces deal with Lilly and Novo on GLP-1 drugs https://www.reuters.com/business/healthcare-pharmaceuticals/novo-lilly-shares-rise-trump-obesity-drug-deal-nears-2025-11-06/ Amylin Agonists Amylin Analog Eloralintide Reduces Weight in Phase 2 Trial https://www.medscape.com/viewarticle/amylin-analog-eloralintide-reduces-weight-phase-2-trial-2025a1000uqf Eloralintide Phase 2 Study https://doi.org/10.1016/S0140-6736(25)02155-5 GLP-1 Comparisons SURMOUNT-5 Trial https://www.nejm.org/doi/10.1056/NEJMoa2416394 Tirzepatide vs Semaglutide in 10-year CVD Risk Reduction https://doi.org/10.1093/ehjopen/oeaf117 IV A Problematic Trial in Stroke Care LAMP trial https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2840370 V AHA Preview AHA 2025: Mandrola's Four Trials to Look For https://www.medscape.com/viewarticle/aha-2025-mandrolas-four-trials-look-2025a1000u80 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

This week we speak with Ohio State ACHD fellow Andrew Freddo MD, PhD about a recent large single center study he conducted assessing the cardiovascular drugs that adult Fontan patients are taking and whether they might offer us insights into general well-being. Are there agents that are associated with worse outcomes? If so, is this a situation of the agent causing harm or is it a possible marker of illness? Are there agents associated with improved outcomes? These are amongst the questions reviewed with Dr. Freddo this week. DOI: 10.1016/j.jacadv.2025.102070

This episode covers: Cardiology this Week: A concise summary of recent studies Lp(a) - What to expect in the very near future Myocardial infarction in older and frail adults Mythbusters: is beetroot good for your heart? Host: Rick Grobbee Guests: JP Carpenter, Vijay Kunadian, Erik Stroes Want to watch that episode? Go to: https://esc365.escardio.org/event/2177 Want to watch that extended interview on Lp(a), go to: https://esc365.escardio.org/event/2177?resource=interview   Disclaimer  ESC TV Today is supported by Bristol Myers Squibb and Novartis through an independent funding. The programme has not been influenced in any way by its funding partners. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. The ESC is not liable for any translated content of this video. The English language always prevails.    Declarations of interests Stephan Achenbach, Yasmina Bououdina, Rick Grobbee, Nicolle Kraenkel, Vijay Kunadian and Erik Stroes have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

This week on Health Matters, we return to Courtney Allison's conversation with sports cardiologist Dr. Sonia Tolani, who explains how exercise changes the heart. These changes are easy to see in elite athletes, Dr. Tolani gives a behind-the-scenes look at the screening process for athletes to ensure their safety in high-level competition. She also describes how teams can prepare for emergency response, and the life-saving measures that everyone should know when it comes to caring for our hearts. ___Dr. Sonia Tolani received her medical degree with honors from New York University School of Medicine. She completed her internship, medical residency and her fellowship in cardiovascular medicine at Columbia University Medical Center in New York City. Dr. Tolani's areas of expertise include consultative cardiology, preventative medicine and women's heart disease including the treatment of gestational hypertension and preeclampsia. She is board-certified in Internal Medicine, Cardiology and Echocardiography. Dr. Tolani is the co-Director of the Columbia Women's Heart Center, a unique program focusing on providing state of the art treatment and preventative care to women of all ages. In addition to her clinical work, Dr. Tolani is also working on developing digital tools to better educate health care providers about heart disease in women and to improve heart disease awareness in women globally.___Health Matters is your weekly dose of health and wellness information, from the leading experts. Join host Courtney Allison to get news you can use in your own life. New episodes drop each Wednesday.If you are looking for practical health tips and trustworthy information from world-class doctors and medical experts you will enjoy listening to Health Matters. Health Matters was created to share stories of science, care, and wellness that are happening every day at NewYork-Presbyterian, one of the nation's most comprehensive, integrated academic healthcare systems. In keeping with NewYork-Presbyterian's long legacy of medical breakthroughs and innovation, Health Matters features the latest news, insights, and health tips from our trusted experts; inspiring first-hand accounts from patients and caregivers; and updates on the latest research and innovations in patient care, all in collaboration with our renowned medical schools, Columbia and Weill Cornell Medicine.To learn more visit: https://healthmatters.nyp.org

Message our hosts, Kieran and Jose.In the finale of The Animal Heartbeat Season 3, Kieran and Jose are once again joined by Dr Mark Rishniw. Double-boarded in Cardiology and Internal Medicine, Mark works as a VIN Consultant and Research Associate of the Simpson Lab at Cornell University College of Veterinary Medicine. Through his numerous educational roles, lectures and publications, Dr Rishniw has become known as a critical thinker who is on a mission to bust myths and break down barriers to communication.In part two, join Mark as he shares his perspectives on coughing in heart failure, and the publication process in 2025.

ReferencesGuerra, DJ. 2025. Unpublished LecturesJBC 2016. Volume 291, Issue 8, 19 February:3932-3946Biomarker Res. 2021. volume 9, Article number: 1 Canadian Journal of Cardiology 2025. Volume 41, Issue 9, September:736-1752Hatdn, M. 1757. Violin Concerto in G Major and Concerto for Harpsichord and Viola.https://music.youtube.com/watch?v=WP2vXExDz5k&si=64zQRYANBuYOInZ2 https://youtu.be/rNSuP-3EYV4?si=0dOEGNF0AKxsN9cw

Cardiovascular-kidney-metabolic (CKM) syndrome is progressive, but can be halted or even reversed with effective management. Guests Chiai Ndumele, MD, PhD, and Joe Saseen, PharmD, BCPS, BCACP, describe the role of inflammation and how the biologic factors for diagnosis and treatment are nested within a patient's social context.2023 AHA Statement Cardiovascular-Kidney-Metabolic Health: https://www.ahajournals.org/doi/10.1161/cir.0000000000001184 Related Resources:PCNA CKM tools and resources: https://pcna.net/resources/patient-education/patient-information/cardiovascular-kidney-metabolic-syndrome-resources/ AHA Cardiovascular Kidney Metabolic Health Presidential Advisory: https://professional.heart.org/en/science-news/cardiovascular-kidney-metabolic-health-a-presidential-advisoryAHA CKM Syndrome Implementation Guide: https://www.heart.org/en/professional/cardiovascular-kidney-metabolic-health/implementationPCNA CKM Resource list: https://pcna.net/resources/patient-education/patient-information/cardiovascular-kidney-metabolic-syndrome-resources/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The bidiretional relationship between cardiac and renal systems means that any dysfunction can cause a cascade of health issues. Learn about team-based care strategies for nurses and other professionals to monitor and manage patients with these conditions from guests Andrew Bzowyckyj, PharmD, BCPS, CDCES, FAPhA, FADCES, and Serina Gbaba, DNP, MBA, FNP-BC.PCNA CKM tools and resources: https://pcna.net/resources/patient-education/patient-information/cardiovascular-kidney-metabolic-syndrome-resources/ IPEC core competencies (Interprofessional Education Collaborative): https://www.ipecollaborative.org/ipec-core-competencies CVD in CKD: Pathophysiological Insights and Therapeutic Options: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.050686Social Determinants of CVD:https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.121.319811See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

* Add FAAN to Anita's creds after Oct. 18.Guests: Anita Rich, DNP, RN, CHFN, CDCES, FAAN, and Jane DeMeis.Related resources:PCNA CKM tools and resources: https://pcna.net/resources/patient-education/patient-information/cardiovascular-kidney-metabolic-syndrome-resources/ 2025 ACC Expert Consensus Statement on Medical Weight Mgmt for Optimization of CV Health: https://www.jacc.org/doi/10.1016/j.jacc.2025.05.024 Adiponectin, Leptin and CV Disorders: (https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.120.314458Racial and Ethnic Disparities in Adult Obesity in the US: https://www.cdc.gov/pcd/issues/2019/18_0579.htmCardiometabolic Syndrome: A Global Health Issue: https://www.uspharmacist.com/article/cardiometabolic-syndrome-a-global-health-issueTaking Aim At Belly Fat: https://www.health.harvard.edu/newsletter_article/taking-aim-at-belly-fatGender Disparities in People Living with Obesity: https://pubmed.ncbi.nlm.nih.gov/34526743/ Systematic review and meta-analysis suggests obesity predicts onset of CKD: https://www.sciencedirect.com/science/article/pii/S0085253816307529AHA Weight-Loss Strategies for Prevention and Treatment of Hypertension: https://pubmed.ncbi.nlm.nih.gov/34538096/ Renal Fat Accumulation Assessed by MRI or CT and Metabolic Disorders: https://pmc.ncbi.nlm.nih.gov/articles/PMC12194363/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Commentary by Dr. Xin Zhou.

Message our hosts, Kieran and Jose.In the first part of our very special, two-part Animal Heartbeat Season 3 finale, Kieran and Jose are joined by Dr Mark Rishniw. Double-boarded in Cardiology and Internal Medicine, Mark works as a VIN Consultant and Research Associate of the Simpson Lab at Cornell University College of Veterinary Medicine. Through his numerous educational roles, lectures and publications, Dr Rishniw has become known as a critical thinker who is on a mission to bust myths and break down barriers to communication.In part one, join Mark as he dissects the topic of NT-proBNP screening for feline cardiomyopathy, and treatment for pets in stage B2...

In this episode of Better Edge, Quentin R. Youmans, MD, assistant professor of Cardiology at Northwestern Medicine Bluhm Cardiovascular Institute, discusses the recent joint scientific statement from the Heart Failure Society of America (HFSA) and the American Society of Preventive Cardiology (ASPC) published in the Journal of Cardiac Failure. This statement explores the integration of multidisciplinary care models in heart failure management, focusing on proactive strategies for early detection and prevention. It also emphasizes the importance of lifestyle modifications, social determinants of health and a shift in language from "failure" to "function" for enhancing patient engagement. Additionally, the research investigates the role of emerging technologies, such as wearables and AI, in revolutionizing care and proposes a cohesive framework that promotes cardiovascular, kidney and metabolic health to reduce heart failure incidence.

C'est une histoire à la fois tragique et révélatrice des dérives du système de santé américain. Sur le réseau Threads, un internaute connu sous le pseudonyme @nthmonkey a raconté comment Claude AI, le chatbot développé par Anthropic, l'a aidé à contester une facture hospitalière de 195 000 dollars — soit près de 180 000 euros — réclamée après le décès de son beau-frère, victime d'une crise cardiaque.Le patient n'était plus couvert par son assurance santé depuis deux mois, et l'hôpital a facturé les quatre dernières heures passées en soins intensifs à un tarif démesuré. En cherchant à comprendre, la famille a d'abord réclamé une ventilation détaillée des coûts. Mais la transparence a tardé à venir : certaines lignes, comme une mention « Cardiology » à 70 000 dollars, restaient sans explication. Après de multiples relances, l'établissement a finalement transmis les codes de facturation médicale standard. C'est là que l'intelligence artificielle est entrée en jeu.Claude AI a analysé les données et détecté plusieurs anomalies flagrantes. La principale : une double facturation. L'hôpital avait facturé à la fois une procédure complète et chacune de ses composantes séparément, une pratique interdite par Medicare. Cette erreur représentait, à elle seule, près de 100 000 dollars de frais injustifiés. L'IA a aussi repéré des incohérences dans les codes d'urgence, des actes ventilatoires facturés deux fois le même jour, et d'autres irrégularités susceptibles de violer les règles de facturation.Mais le plus surprenant, c'est que Claude AI n'a pas seulement servi d'auditeur numérique : le chatbot a également rédigé des lettres de contestation juridiques, évoquant les risques d'actions en justice et de mauvaise publicité pour l'hôpital. Résultat : la facture a été ramenée à 33 000 dollars. Pour @nthmonkey, cette expérience révèle à quel point les établissements de santé profitent souvent de la complexité administrative, en espérant que les familles n'oseront pas contester. L'IA, elle, a permis de rétablir un semblant de justice dans un système où la moindre erreur se chiffre en dizaines de milliers de dollars. Une première victoire symbolique de la technologie contre les excès de la bureaucratie médicale américaine. Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

Four pillars of cardiology today, stable coronary artery disease, severe aortic stenosis, the evaluation of chest pain, and best therapies for atrial fibrillation are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I Stable CAD Complete vs culprit-only revascularization at time of STEMI iMODERN Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2512918 PRAMI Trial https://www.nejm.org/doi/full/10.1056/NEJMoa1305520 COMPLETE Trial https://www.nejm.org/doi/full/10.1056/NEJMoa1907775 FULL REVASC Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2314149 PCI Revascularization Strategies After MI https://www.jacc.org/doi/10.1016/j.jacc.2024.04.051 CULPRIT SHOCK Trial https://www.nejm.org/doi/full/10.1056/NEJMoa1710261 How a Meta-Analysis Can Mislead https://www.sensible-med.com/p/how-a-meta-analysis-can-misleadthe II SEVERE Aortic Senosis 7-Year PARTNER 3 Results – TAVI vs SAVR 7-year results PARTNER 3 https://www.nejm.org/doi/full/10.1056/NEJMoa2509766 PARTNER 3 at 1 year https://www.nejm.org/doi/10.1056/NEJMoa1814052 PARTNER 3 at 5 years https://www.nejm.org/doi/10.1056/NEJMoa2307447 III Functional vs Anatomic Assessment in Suspected CAD 10-year follow-up of PROMISE trial https://jamanetwork.com/journals/jamacardiology/fullarticle/2838118 PROMISE Trial https://www.nejm.org/doi/10.1056/NEJMoa1415516 CCTA vs Functional Stress Test – Meta-Analysis https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2655243 IV ARREST AF ARREST AF trial https://jamanetwork.com/journals/jamacardiology/fullarticle/2840225 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

This week we review the results of the new pivotal trial of the 'Minima' stent by Renata Medical. What is special about this new device that makes it particularly desirable for use in small children? How strong is cobalt chromium and what evidence exists that it can be expanded repeatedly over 1-2 decades? Can this technology supplant surgery for certain diseases such as native coarctation? What are the limitations of this device? We speak with the first author of the pivotal trial, Dr. Patrick Sullivan of CHLA who is Associate Professor of Pediatrics at Keck Medicine at USC. DOI: 10.1161/CIRCINTERVENTIONS.125.015618

Dr. Matthew Budoff discusses Preventative Cardiology with moderator Dr. Ben Weitz at the Functional Medicine Discussion Group meeting on September 25, 2025. This was the second annual Dr. Howard Elkin memorial Preventative Cardiology lecture. [If you enjoy this podcast, please give us a rating and review on Apple Podcasts, so more people will find The Rational Wellness Podcast. Also check out the video version on my WeitzChiro YouTube page.] Podcast Highlights Dr. Matthew Budoff is a professor of medicine at the David Geffen School of Medicine at UCLA, Program Director and Director of Cardiac-CT, Division of Cardiology, Harbor-UCLA Medical Center and he is an investigator with The Lundquist Institute https://lundquist.org/matthew-budoff-md. Dr. Budoff's research is devoted to advancing procedures that can help doctors identify patients early that are at high-risk for cardiac events and progression of atherosclerosis. This early detection can lead to patients being placed on the correct therapeutic path to prevent a heart attack. Additionally, Dr. Budoff's research focuses on determining the effect of different therapies on atherosclerosis and determine if heart disease can be reversed. His office is in Torrance, California and his office number is 310-222-2773. Dr. Ben Weitz is available for Functional Nutrition consultations specializing in Functional Gastrointestinal Disorders like IBS/SIBO and Reflux and also Cardiometabolic Risk Factors like elevated lipids, high blood sugar, and high blood pressure. Dr. Weitz has also successfully helped many patients with managing their weight and improving their athletic performance, as well as sports chiropractic work by calling his Santa Monica office 310-395-3111.

With Sotiria Liori, Attikon University Hospital, National and Kapodistrian University of Athens - Greece and Julie De Backer, Ghent University Hospital - Belgium. In this episode, Sotiria Liori and Julie De Backer discuss heart failure in adult congenital heart disease patients — covering how congenital lesions and prior repairs shape epidemiology and mechanisms (ventricular remodeling, valvular and conduit dysfunction, arrhythmias), as well as clinical assessment with imaging, biomarkers, and hemodynamics. They outline management with guideline-directed therapy, rhythm considerations, indications for advanced therapies (MCS and transplant), and pregnancy counseling. The episode also highlights multidisciplinary care models and key evidence gaps. Proposed reading:  General Principles of Heart Failure Management in Adult Congenital Heart Disease. Tompkins R, Romfh A. Heart Failure Reviews. 2020;25(4):555-567. doi:10.1007/s10741-019-09895-x Chronic Heart Failure in Congenital Heart Disease: A Scientific Statement From the American Heart Association. Stout KK, Broberg CS, Book WM, et al. Circulation. 2016;133(8):770-801. doi:10.1161/CIR.0000000000000352. Relation Between New York Heart Association Functional Class and Objective Measures of Cardiopulmonary Exercise in Adults With Congenital Heart Disease. Das BB, Young ML, Niu J, et al. The American Journal of Cardiology. 2019;123(11):1868-1873. doi:10.1016/j.amjcard.2019.02.053.  Heart Failure and Patient-Reported Outcomes in Adults With Congenital Heart Disease from 15 Countries. Lu CW, Wang JK, Yang HL, Kovacs AH, et al; APPROACH‐IS consortium, the International Society for Adult Congenital Heart Disease (ISACHD) *.J Am Heart Assoc. 2022 May 3;11(9):e024993. doi: 10.1161/JAHA.121.024993. Epub 2022 Apr 26. Pharmacological Therapy in Adult Congenital Heart Disease: Growing Need, Yet Limited Evidence. Brida M, Diller GP, Nashat H, et al. European Heart Journal. 2019;40(13):1049-1056. doi:10.1093/eurheartj/ehy480. Advanced Heart Failure Therapies For Adults With Congenital Heart Disease: JACC State-of-the-Art Review. Givertz MM, DeFilippis EM, Landzberg MJ, et al. Journal of the American College of Cardiology. 2019;74(18):2295-2312.doi:10.1016/j.jacc.2019.09.004. A Review of Heart Transplantation for Adults With Congenital Heart Disease. McMahon A, McNamara J, Griffin M. Journal of Cardiothoracic and Vascular Anesthesia. 2021;35(3):752-762. doi:10.1053/j.jvca.2020.07.027. Heart Failure in Adult Congenital Heart Disease: From Advanced Therapies to End-of-Life Care. Crossland DS, Van De Bruaene A, Silversides CK, Hickey EJ, Roche SL. The Canadian Journal of Cardiology. 2019;35(12):1723-1739. doi:10.1016/j.cjca.2019.07.626. This 2025 HFA Cardio Talk podcast series is supported by Bayer AG in the form of an unrestricted financial support. The discussion has not been influenced in any way by its sponsor. 

Drs Harrington, Rodriguez, and Ridker discuss the changing field of cardiac prevention, where imaging fits in, and the new concept of standard modifiable risk factor-less patients. This podcast is intended for healthcare professionals only. To read a transcript or to comment, visit https://www.medscape.com/author/bob-harrington Life's Essential 8: Updating and Enhancing the American Heart Association's Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association https://doi.org/10.1161/CIR.0000000000001078 Development and Validation of the American Heart Association's PREVENT Equations https://doi.org/10.1161/CIRCULATIONAHA.123.067626 C-Reactive Protein and Cardiovascular Risk Among Women With No Standard Modifiable Risk Factors: Evaluating the 'Smurf-Less but Inflamed' https://doi.org/10.1093/eurheartj/ehaf658 Mortality in STEMI Patients Without Standard Modifiable Risk Factors: A Sex-Disaggregated Analysis of SWEDEHEART Registry Data https://doi.org/10.1016/S0140-6736(21)00272-5 Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women https://www.nejm.org/doi/10.1056/NEJMoa2405182 Statins for the 'SMuRFLess But Inflamed': Silent Vascular Inflammation and the Challenge of Translational Science https://doi.org/10.1016/j.jacbts.2025.101318 VERVE-101: A Promising CRISPR-Based Gene Editing Therapy That Reduces LDL-C and PCSK9 Levels in HeFH Patients https://academic.oup.com/ehjcvp/article/10/2/89/7492807 You may also like: Hear John Mandrola, MD, give a summary and his perspective on the top cardiology news each week, on This Week in Cardiology https://www.medscape.com/twic Questions or feedback, please contact news@medscape.net

WXPR News for 10-28-25

The PREVENT score in hypertension, GLP-1 mechanism of action in cardiovascular disease, CAD type and statin benefit, and the problem with hospitalization endpoints in HF trials are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I Is the PREVENT Calculator Best for Determining CVD Risk? Insights From a Post Hoc Analysis of SPRINT Trial https://www.medscape.com/viewarticle/prevent-calculator-best-determining-cvd-risk-insights-post-2025a1000svo PREVENT Calculator https://doi.org/10.1016/j.jacc.2025.07.037 SPRINT Trial https://www.nejm.org/doi/full/10.1056/NEJMoa1511939 II GLP-1 Mechanism of Action in CV Disease Analysis of SELECT Trial 10.1016/S0140-6736(25)01375-3 External Link SELECT trial https://www.nejm.org/doi/full/10.1056/NEJMoa2307563 III Statins and CAD Phenotype on CTA and Outcomes Interactions Between Statin Use, CAD Phenotypes on CTA  https://www.jacc.org/doi/10.1016/j.jcmg.2025.05.018 Statin Use for Primary Prevention of CVD https://jamanetwork.com/journals/jama/fullarticle/2795522 IV HHF Endpoints in Heart Failure Trials The Problem with Hospitalization Endpoints in HF Trials https://onlinelibrary.wiley.com/doi/10.1002/ejhf.70070 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

This week we review a recent survey study assessing the beliefs of fetal cardiologists and how these may influence the content and conduct of their counseling. Do most fetal cardiologists review all options including intervention, comfort care and pregnancy termination? Should there be a mandate that all do? Is it realistic or appropriate to ask a fetal cardiologist to suggest an option when they do not believe it to be a reasonable or correct choice? We speak with two of the authors of this work and they are Dr. Joanne Chiu of Harvard University and Dr. Caitlin Haxel of The University of Vermont. DOI: 10.1002/pd.6706

A new European Society of Cardiology clinical consensus statement deals with cardiovascular disease prevention and management in COVID-19, including cardiac long COVID. The report's lead author, Vassilios Vassiliou, MBBS, PhD, MA, discusses the guidance and key questions that remain about COVID-19 and the heart. Related Content: New Guidance on Cardiovascular Disease and COVID-19—From Infection to Long COVID to Vaccination

Surgeon's Secret Camera Captured Wife's Affair; Now I'm Head of Cardiology & FreeBecome a supporter of this podcast: https://www.spreaker.com/podcast/true-cheating-wives-and-girlfriends-stories-2025-true-cheating-stories-podcast--5689182/support.

This episode covers: Cardiology This Week: A concise summary of recent studies Arrhythmias in cardiac amyloidosis Taking the 'O' out of HOCM: managing LVOT obstruction Snapshots Host: Susanna Price Guests: Carlos Aguiar, Stephanie Schwarting, Ahmad Masri Want to watch that episode? Go to: https://esc365.escardio.org/event/2176 Want to watch that extended interview on Arrhythmias in Cardiac Amyloidosis? Go to: https://esc365.escardio.org/event/2176?resource=interview Disclaimer: ESC TV Today is supported by Bristol Myers Squibb and Novartis through an independent funding. The programme has not been influenced in any way by its funding partners. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. The ESC is not liable for any translated content of this video. The English language always prevails. Declarations of interests: Stephan Achenbach, Yasmina Bououdina, Nicolle Kraenkel and Susanna Price have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder Mycardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Ahmad Masri has declared to have potential conflicts of interest to report: research grants from Pfizer, Ionis, Attralus, Cytokinetics and Janssen. Consulting fees from Cytokinetics, BMS, BridgeBio, Pfizer, Ionis, Lexicon, Attralus, Alnylam, Haya, Alexion, Akros, Edgewise, Rocket, Lexeo, Prothena, BioMarin, AstraZeneca, Avidity, Neurimmune, and Tenaya. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Stephanie Schwarting has declared to have potential conflicts of interest to report: advisory board for Alnylam, Bayer, Pfizer; principal investigator in trials sponsored by Alexion, Novo Nordisk and Intellia. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Host: Susanna Price Guest: Stephanie Schwarting Want to watch the episode? Go to: https://esc365.escardio.org/event/2176 Want to watch the extended interview on Arrhythmias in Cardiac Amyloidosis? Go to: https://esc365.escardio.org/event/2176?resource=interview Disclaimer: ESC TV Today is supported by Bristol Myers Squibb and Novartis through an independent funding. The programme has not been influenced in any way by its funding partners. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. The ESC is not liable for any translated content of this video. The English language always prevails. Declarations of interests:  Stephan Achenbach, Yasmina Bououdina, Nicolle Kraenkel and Susanna Price have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder Mycardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada.  Stephanie Schwarting has declared to have potential conflicts of interest to report: advisory board for Alnylam, Bayer, Pfizer; principal investigator in trials sponsored by Alexion, Novo Nordisk and Intellia. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

With Jean-Benoit Le Polain de Waroux, St-Jan Hospital, Brugge - Belgium, and Maarten De Smet, AZ Sint Jan, Brugge - Belgium.  Link to European Heart Journal paper Link to European Heart Journal editorial

Send us a textToday we are releasing another bonus episode! This is my recent appearance on the IFixHearts YouTube Channel, hosted by Chris S. Cornell!As always, it was a fun chat, and I'm always so grateful to be a guest on someone else's show!Find I Fix Hearts by Dr. Ovadia at-YT- @I Fix Hearts by Dr. OvadiaFind Boundless Body at- myboundlessbody.com Book a session with us here!

Tackle High-Yield Concepts for USMLE Step 2 CK Cardiology This interactive session, led by Dr. Abraham Titus (Hematology/Oncology Fellow, University of South Alabama) and ScholarRx’s Jeff Downing, focuses on challenging USMLE Step 2 CK cardiology questions that will sharpen your clinical decision-making skills and deepen your understanding of cardiovascular medicine. WHAT YOU’LL LEARN: In this episode, we work through four board-style questions using our proven systematic approach that helps you think like a clinician first, then a test-taker second. You’ll learn how to apply clinical guidelines and make evidence-based management decisions through detailed explanations that go beyond just identifying the correct answer. Topics Covered: Cardiovascular risk management and pharmacotherapy Acute coronary syndrome management strategies Peripheral vascular disease evaluation and treatment Secondary hypertension workup and management Perfect for: Medical students preparing for USMLE Step 2 CK Clinical year medical students on cardiology rotations IMGs studying for board exams Anyone looking to strengthen their cardiology clinical reasoning Review the full test: https://usmle-rx.scholarrx.com/share/1do75erd2wnmg0y Free Resources: Biochemistry Course: https://usmle-rx.com/biochemistry-course/ More Rx Bricks Podcasts: https://usmle-rx.com/podcast Study Planner: https://go.usmle-rx.com/study-schedule/

Another knock against the antiplatelet/anticoagulant combo, polypills in HF, the physical exam of the future, and the problem of underpowered trials that even Bayesian analyses cannot rescue are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I Listener Feedback Trends Study https://www.heartrhythmjournal.com/article/S1547-5271(11)00496-6/fulltext II Another knock against the Antiplatelet/Anticoagulation combination “Antiplatelet Plus Oral Anticoagulant Lowers Stroke, Raises Bleeding Risk” https://www.medscape.com/viewarticle/antiplatelet-plus-oral-anticoagulant-lowers-stroke-raises-2025a1000re0 ATIS-NVAF Trial https://jamanetwork.com/journals/jamaneurology/fullarticle/2839511 AQUATIC trial https://www.nejm.org/doi/abs/10.1056/NEJMoa2507532 III Polypill for HFrEF A Multilevel Polypill for Patients With HFrEF https://www.jacc.org/doi/10.1016/j.jacadv.2025.102195 IV The Physical Exam of the Future Point-of-Care Ultrasound https://doi.org/10.1016/j.jchf.2025.102707 V More on Underpowered Trials – GA vs Moderate Sedation in IV stroke SEGA Trial https://jamanetwork.com/journals/jamaneurology/fullarticle/2839838 Bayesian Analyses of CV Trials https://doi.org/10.1016/j.cjca.2021.03.014 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

This week we review an episode from 3 years back and delve into the world of adult congenital heart disease when we review a recent work from the ACHD team at UCSF that assesses the impact of BMI on clinical outcomes in the single ventricle adult Fontan patient. What is the cause of elevation in BMI in some Fontan patients? Is obesity the only explanation? Is BMI a modifiable risk factor for our Fontan patients and should exercise be 'prescribed' for these patients? If so prescribed, what type of exercise is best for the Fontan patient? This week's work's senior author, Dr. Anushree Agarwal, Assistant Professor of Medicine at UCSF, shares her insights into this important topic. DOI: 10.1161/JAHA.122.026732Also mentioned in today's episode is episode #222 with Dr. Dan Halpern of NYU medical center (https://www.stitcher.com/show/pediheartpediatric-cardiology-today/episode/pediheart-podcast-222-impact-of-cardiac-rehab-on-exercise-tolerance-in-the-achd-patient-206781483)

In this solo episode, Darin takes on the “beef tallow” craze that's been sweeping the wellness world — exposing the industry manipulation, environmental costs, and scientific inaccuracies behind the trend. From skincare to supplements, companies are selling animal byproducts as miracle cures — but what's really happening behind the scenes? Darin dives into the industrial rendering process, the hidden pollution of factory farming, and the false “ancestral” marketing that's convincing people to buy into a billion-dollar rebrand of waste. This episode isn't about guilt — it's about truth, awareness, and sovereignty. Because when you know how the system really works, you can choose differently.     What You'll Learn 00:00:00 – Why Darin decided to peel back the layers on the beef tallow trend 00:01:00 – What tallow actually is: industrially rendered animal fat from slaughterhouse byproducts 00:03:00 – The dirty details: high-heat rendering, bleaching, deodorizing, and chemical refining 00:06:00 – The hidden foundation of factory farming and the myth of “ancestral” sourcing 00:08:00 – The human and environmental toll of the tallow supply chain — pollution, stress, and labor exploitation 00:10:00 – Marketing manipulation: how “natural” language disguises industrial exploitation 00:12:00 – Science check: why tallow isn't nutritionally superior to seed oils 00:14:00 – The clinical data: saturated vs. polyunsaturated fats and heart health 00:16:00 – The real safety issues — prion disease, contaminants, oxidation, and hidden toxins 00:18:00 – Why skincare claims are unproven — no data shows tallow outperforms plant oils 00:20:00 – The illusion of “zero-waste”: how byproduct economics fuel more slaughter 00:22:00 – What “natural” actually costs — to the planet, animals, and human health 00:24:00 – The path forward: transparency, awareness, and choosing regenerative alternatives 00:26:00 – The SuperLife perspective: stop calling destruction natural — awareness is the first step toward change     Thank You to Our Sponsors Fatty15: Get an additional 15% off their 90-day subscription Starter Kit by going to fatty15.com/DARIN and using code DARIN at checkout. EnergyBits: 100% spirulina and chlorella tablets delivering pure food nutrition. Use code SUPERLIFE for 20% off at energybits.com.     Find More from Darin Olien: Instagram: @darinolien Podcast: SuperLife Podcast Website: superlife.com Book: Fatal Conveniences     Key Takeaway “Let's stop calling destruction natural. When we stop buying into exploitation, we stop funding it — and that's when change begins for the animals, for the planet, and for us.”     Bibliography / Key References Meatscience.org, “Rendering 101” (industry rendering overview) FAO / Codex Alimentarius, edible fats and oils specifications (MIU, peroxide, etc.) Sölens / rendering-industry chemical supplier blogs (on refining aids, odor control) FDA/EPA dioxin/PCB in fats monitoring programs AHA/ACC (American Heart Association / American College of Cardiology) review on saturated vs unsaturated fats and cardiovascular disease PubMed articles on prion resistance to rendering Derm & cosmetic reviews on tallow/animal fats in skincare Industry & environmental NGO reports on factory farming's greenhouse gas, water, land use, manure pollution, worker conditions

We kicked off the program with four news stories and different guests on the stories we think you need to know about!The Nova Exhibition, honoring the Tribe of Nova massacre with relics and survivor stories, runs in South Boston through Oct. 21. Guest: Tal Mazor – Nova Festival Survivor What motorists need to be aware of with seeing more moose and deer on the roadways this Fall.  Guest: Martin Feehan - Deer & Moose Biologist, Wildlife Health Specialist at Massachusetts Division of Fisheries & Wildlife With the release of the Israeli hostages, we discuss the neuroscience of trauma and survival. Guest: Dr. Nicholas Wright - leading neuroscientist and adviser to the Pentagon, author of book: WARHEAD: How the Brain Shapes War and War Shapes the Brain With Halloween coming up, we discuss how watching scary movies or engaging in spooky activities like going to a haunted house, impacts your heart. Should certain people forgo getting “scared”? Guest: Dr. James Udelson - Chief of Cardiology at Tufts Medical Center

The air inside and outside your home often contains invisible pollutants, including fine particles and gases from traffic, industry, and household items, which accumulate in the spaces where you spend the most time Fine particulate matter (PM2.5), in particular, which is about 30 times smaller than a human hair, penetrates deeply into your lungs and bloodstream, where it contributes to cardiovascular strain and disease A large, randomized crossover trial published in the Journal of the American College of Cardiology found that using HEPA air filters indoors significantly lowered PM2.5 exposure and reduced systolic blood pressure Research links long-term air pollution to many serious health risks beyond heart disease, including respiratory illnesses, lung cancer, impaired childhood development, heightened infection rates, and neurological conditions Aside from installing HEPA filtration systems at home, other strategies to reduce your exposure to air pollutants include switching to nontoxic household products, ventilating wisely, filtering water, and reducing outdoor exposure on polluted days

GLP-1 use in HFrEF, left atrial posterior wall isolation during AF ablation, peri-device leaks for LAAO, new findings in post-cardiac surgery AF, and imaging before AF ablation are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I. Listener Feedback HYPERION trial https://www.nejm.org/doi/10.1056/NEJMoa2508170 ZENITH trial https://www.nejm.org/doi/full/10.1056/NEJMoa2415160 II GLP1 Use in HFrEF Effects of GLP-1s in Patients With HFrEF https://doi.org/10.1016/j.jchf.2025.102573 FIGHT Study https://jamanetwork.com/journals/jama/fullarticle/2540402 FIGHT Study Post-hoc Analysis https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.14862 Substudy of EXSCEL Trial https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.119.041659 III LA Posterior Wall Isolation Saga Failure of PW Wall Isolation by PFA with Epicardial Mapping https://doi.org/10.1016/j.jacep.2025.08.017 IV Peridevice Leaks After LAAO IMPRESSION LAAC Study https://doi.org/10.1016/j.jacep.2025.08.014 V Post Cardiac Surgery AF Monitoring of New-Onset AF After CABG https://jamanetwork.com/journals/jama/fullarticle/2839710 PACES trial https://clinicaltrials.gov/study/NCT04045665 VI TEE vs ICE Before AF ablation ICE vs TEE Study https://jamanetwork.com/journals/jamacardiology/fullarticle/2839370 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

This week we review a recent work from the "Women In Pediatric Cardiology" group which is a 4 year old initiative to help lift up women pediatric cardiologists through the fostering of connections and also via mentorship programs. Why did this program develop and what are the most pressing issues affecting female pediatric cardiologists? What are the best solutions to help address gender inequities in our field? We speak with two co-authors of this week's work, Drs. Sarah Ford of Brown University and Kristin Laraja of University of Massachussetts. For those interested in participating in their work, feel free to email  Pediheart@gmail.com and your information will be passed along to the authors. DOI: 10.1007/s00246-024-03576-9

In this powerful kickoff to a collaborative series with the AHA Women in Cardiology (WIC) Committee, CardioNerds (Dr. Apoorva Gangavelli, Dr. Gurleen Kaur, and Dr. Jenna Skowronski) explore the evolving landscape of women in advanced heart failure and transplant cardiology, featuring insights from two inspiring leaders in the field. Dr. Mariell Jessup, Chief Science and Medical Officer of the American Heart Association, reflects on her decades-long journey in heart failure cardiology, from navigating early career barriers to becoming a trailblazer in clinical leadership and research. Dr. Nosheen Reza, an advanced heart failure and transplant cardiologist at the University of Pennsylvania, shares how Dr. Jessup's pioneering work has inspired her own career and shaped her approach to mentorship, advocacy, and academic development. Together, they discuss the systemic challenges women continue to face, the importance of sponsorship, and the evolving culture within cardiology. Listeners will gain a multigenerational perspective on how far the field has come and what is still needed to ensure equity, excellence, and innovation in advanced heart failure care. Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. CardioNerds Heart Success Series PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! References DeFilippis EM, Moayedi Y, Reza N. Representation of Women Physicians in Heart Failure Clinical Practice. Card Fail Rev. 2021;7:e05. Published 2021 Mar 31. doi:10.15420/cfr.2020.31 

Two great stories of translation science leading to beneficial drugs in terrible diseases of the heart and the Sisyphean task of predicting the need for pacing after TAVI are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I Sotatercept HYPERION Trial https://www.nejm.org/doi/10.1056/NEJMoa2508170 ZENITH Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2415160 Evidence report on treatment for PAH https://icer.org/news-insights/press-releases/icer-publishes-final-evidence-report-on-treatment-for-pulmonary-arterial-hypertension/ PAH Sotatercept Editorial https://www.nejm.org/doi/full/10.1056/NEJMe2503944 II Acoramidis and ATTR Cardiomyopathy ATTRIBUTE-CM Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2305434?logout=true ATTRIBUTE-CM Analysis - Substudy https://www.jacc.org/doi/10.1016/j.jacc.2025.09.013 Tafamadis Trial https://www.nejm.org/doi/full/10.1056/NEJMoa1805689 III Pacing After TAVI Prophylactic pacemaker after TAVI https://www.jacc.org/doi/10.1016/j.jacep.2025.07.028 PROMOTE study https://doi.org/10.1016/j.hrthm.2024.12.019 Evaluation of ESC criteria on RBBB patients undergoing TAVI https://doi.org/10.1016/j.hrthm.2024.11.030 Editorial on Heart Rhythm journal papers https://www.heartrhythmjournal.com/article/S1547-5271(25)00114-6/abstract You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net